[en] The effectiveness of Synthetic Salmon Calcitonin (SSCT) administered as a nasal spray was assessed via clinical, biological, and radiological variables in 5 Pagetic patients during a 6 months course therapy, the results show that intranasal administration does not decrease the activity of SSCT in Paget's disease of bone.
Disciplines :
General & internal medicine
Author, co-author :
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique
Franchimont, Paul
Language :
English
Title :
Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients
Publication date :
1985
Journal title :
Calcified Tissue International
ISSN :
0171-967X
eISSN :
1432-0827
Publisher :
Springer Verlag, New York, United States - New York
Meunier P.J. (1975) La maladie de Paget. Histologie quantative et prescriptions therapeutiques. Lyon Med 233:839-853.
Fournier A. (1975) Traitment de la maladie de Paget par la Calcitonine. Rev Med Toulouse 11:655-684.
Gennari C., Cecchetin M., Passeri M., Francini G., Gonelli S., Nami R., Bigazzi S. (1983) Gli effetti collaterali di differenti Calcitonine. Calcitonin in man , C., Gennari, G., Segre, Masson, Milano; 93-101.
Trayser K.A., Seligson D. (1969) A new kinetic method for enzyme analysis suitable for automation. Clin Chem 15:452.
Zerbe G.O. (1979) Randomization analysis of the completely randomized design extended to growth and response curves. Journal of the American Statistical Association 74:215-221.
Dietrich F.M., Fischer J.A. (1977) Immunological studies with synthetic human Calcitonin. Human calcitonin and Paget's disease , I., MacIntyre, Hans Huber Publishers, Bern, Stuttgart. Vienna; 179-194.
